Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: The Peregrine Post-Market Study for the Treatment of Hypertension [NA]

View source ↗

Summary

Post-market study completed for a hypertension treatment; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peregrine

Snippet

Sponsor: Ablative Solutions, Inc. | Conditions: Hypertension | NA | Status: COMPLETED | Results posted: 2023-09-28